E10.37
Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment
Clinical Classification Guidelines
7th Character Definition
One of the following 7th characters is to be assigned to code E10.37 to designate laterality of the disease:
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic condition where the body's immune system attacks insulin-producing cells in the pancreas, leading to high blood sugar levels. In some cases, diabetes can lead to complications such as diabetic macular edema (DME), which affects the eyes due to fluid accumulation in the retina. The ICD-10 code E10.37 specifically refers to cases where DME occurs alongside Type 1 diabetes but resolves after treatment. Understanding this condition involves exploring its causes, how it manifests, the diagnostic process, and available treatments.
Causes & Symptoms
Clinical Causes: Diabetic macular edema results from long-standing high blood sugar levels that damage blood vessels in the retina. The primary contributing factors include: - Poorly controlled blood sugar levels - Chronic high blood pressure - Elevated cholesterol levels - Duration of diabetes (the longer the duration, the higher the risk) - Existing diabetic retinopathy - Inflammation and increased vascular permeability in retinal blood vessels
Key Symptoms: Patients with diabetic macular edema may experience various visual disturbances, often indicating the presence of swelling or fluid in the retina. Common symptoms include: - Blurred or distorted vision - Visual acuity loss in one or both eyes - Colors appearing faded or washed out - Central vision loss in affected eye(s) - Difficulty reading or recognizing faces - No initial symptoms in early stages, making regular eye exams important for early detection
Diagnostic & Treatment
Diagnosis Path: Diagnosing diabetic macular edema involves a comprehensive eye examination, including: - Visual acuity tests to measure clarity of vision - Dilated eye exam to inspect the retina and blood vessels - Optical coherence tomography (OCT) imaging to visualize retinal thickness and fluid accumulation - Fluorescein angiography to evaluate blood vessel leakage and integrity These diagnostic tools help determine the presence and severity of edema and guide treatment planning.
Treatment Protocols: Effective management of diabetic macular edema often results in resolution of the swelling following appropriate treatment. Common approaches include: - Anti-vascular endothelial growth factor (anti-VEGF) injections to reduce vascular leakage - Focal/grid laser therapy to seal leaking blood vessels - Corticosteroid injections or implants to decrease inflammation - Strict blood sugar control to prevent further retinal damage - Managing blood pressure and cholesterol levels - Regular monitoring through follow-up eye exams The goal of treatment is to reduce retinal swelling, preserve vision, and prevent recurrence. In cases where the edema resolves, ongoing management of diabetes and eye health remains essential to avoid future complications.
Clinical Advice & FAQs
Billing Guidance
Is E10.37 a billable ICD-10 code?
Yes, E10.37 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.37?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
